Market Overview

Orthofix Offers Comment on Judge's Ruling from Dec. 13th

Related OFIX
Mox's Negative Orthofix Report; Cites 'FDA Issue And Accounting Manipulation'
BMO Capital Highlights This Week's MedTech Earnings

Orthofix International N.V., (NASDAQ: OFIX) (the Company) commented today on the federal court's second rejection of the previously signed plea agreement between the Department of Justice and Orthofix Inc., a subsidiary of the Company, to resolve the bone growth stimulation criminal investigation.

At a hearing yesterday the court rejected the plea agreement emphasizing certain institutional concerns with binding the court's sentencing discretion in such a proceeding. The court invited the Government and Orthofix to provide to the court a joint recommendation on sentencing which would not be binding on the court.

Posted-In: News Legal


Related Articles (OFIX)

View Comments and Join the Discussion!